1 completed. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
Follow NF1: new trials by email Literature Review of NF1 trials Research Report on NF1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Tasigna - Neurofibromatosis, NF1 | Early Phase 1 | Completed | Indiana University | 6 | 2011-01-01 | 2017-04-12 |
Neurofibroma (1) · Neurofibroma, Plexiform (1) · Neurofibromatoses (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Nerve Tissue (1) · Neoplastic Syndromes, Hereditary (1) · Nerve Sheath Neoplasms (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neurocutaneous Syndromes (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1) · Peripheral Nervous System Diseases (1) · Peripheral Nervous System Neoplasms (1)
nilotinib (1)
United States (1)